Restorative Therapies

Restorative Therapies is a long-standing, private commercial-stage company and a global leader in integrated Functional Electrical Stimulation (FES) devices for neurorehabilitation. With over 20 years of experience, it offers a proven product portfolio, including the RT300 and Xcite2 systems, which are used to restore function, improve mobility, and manage secondary complications in patients with neurological impairments. The company operates a B2B2C business model, targeting clinics, rehabilitation centers, and directly supporting patients and veterans with home-based therapy, supported by clinical training and reimbursement assistance. Its strategic focus is on enabling the transition from clinic to home care to drive long-term patient outcomes.

Integrated Functional Electrical Stimulation (FES) systems that deliver controlled electrical impulses to activate weak or paralyzed muscles, coordinated with voluntary effort or specific functional activities to promote neuroplasticity and restore movement.

The neurorehabilitation device market is fragmented, with competition from large physiotherapy equipment manufacturers, specialized FES companies, and emerging robotics/AI firms. Restorative Therapies differentiates through its integrated, activity-based FES approach, strong clinical legacy, and dual focus on clinic and home care.